Notice ID: d5e8a7f7b5bb49419998692e696ebc03Combined Synopsis/Solicitation
Screening of OTC Drug Products.
Archived on September 16, 2023. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 3:30 PM UTC−04:00
- Posted
- August 29, 2023
- Notice type
- Combined Synopsis/Solicitation
- NAICS
- 541380: Testing Laboratories and Services
- Agency
- Department of Health and Human ServicesFOOD AND DRUG ADMINISTRATION
Notice details
- Office
- FDA CENTER FOR DRUG EVALUATION AND RESEARCH
- Last updated
- Dec 4, 2025
Identifiers
- Solicitation number
- 75F40123R00140
- Notice ID
- d5e8a7f7b5bb49419998692e696ebc03
Description
See Attachment for RFP 8/29/2023: Contractor Questions and Government Responses, See Attachment
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
75F40123R00140- Combined Synopsis
- 2×Combined SynopsisCurrentAug 23, 2023
Screening of OTC Drug Products.
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
75F40123R00140
Archive Date
Sep 16, 2023
Office Address
Silver Spring, MD, 20993